Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Aptose Biosciences Inc. | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - Aptose Biosciences Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - Aptose Biosciences Inc. | exh_311.htm |
| EX-23.1 - EXHIBIT 23.1 - Aptose Biosciences Inc. | exh_231.htm |
| EX-21.1 - EXHIBIT 21.1 - Aptose Biosciences Inc. | exh_211.htm |
| EX-10.7 - EXHIBIT 10.7 - Aptose Biosciences Inc. | exh_107.htm |
| EX-4.1 - EXHIBIT 4.1 - Aptose Biosciences Inc. | exh_41.htm |
| 10-K - FORM 10-K - Aptose Biosciences Inc. | f10k_031020p.htm |
Exhibit 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Gregory K. Chow, the Executive President and Chief Financial Officer of Aptose Biosciences Inc. (the “Company”), hereby certify that, to my knowledge:
1. The Annual Report on Form 10-K for the year ended December 31, 2019 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 10, 2020
|
|
/s/ Gregory K. Chow Name: Gregory K. Chow Title: Executive Vice President and Chief Financial Officer |